TCON Kapitalisasi Akuntansi traconpharma.com

Logo perusahaan publik TRACON Pharmaceuticals Inc. (TCON)

TRACON Pharmaceuticals (TCON) is currently experiencing a stagnation due to research failures while awaiting an asset portfolio update by 2026. The business relies on the development of targeted cancer antibodies, sharing testing costs with global partners. This price action chart, where the indicator stands at -0.00, completes the picture. However, military conflicts and sanctions are disrupting logistics, leading to financial losses as overseas trials are halted.

traconpharma.com (TCON) - Nilai Buku Perusahaan saka 04.07.2022 nganti 04.08.2024

Ringkesan rincian data analitis TRACON Pharmaceuticals, Inc. (TCON)

- rega lan prakiraan konsensus rega:
Rega bursa TRACON Pharmaceuticals, Inc|TCON - Bagan rega target
- data kapitalisasi pasar:
Kapitalisasi pasar TRACON Pharmaceuticals Inc.|TCON - Nilai Perusahaan
- data kapitalisasi buku:
Ekuitas saben Saham TRACON Pharmaceuticals|TCON - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku traconpharma.com|TCON - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal TRACON Pharmaceuticals|TCON - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal TRACON Pharmaceuticals Inc.|TCON - Utang perusahaan|Rasio utang marang aset resik TRACON Pharmaceuticals Inc.
Analisis fundamental perusahaan:TCON - TRACON Pharmaceuticals, Inc
Produk asil prodhuksi traconpharma.com

To minimize investment risks, it is critical to track the residual value of net assets minus all liabilities. In the event of a TRACON Pharmaceuticals (TCON) business liquidation and the winding down of oncology developments, the current book capitalization value becomes the primary indicator of the real value of the liquidated assets. Analyzing this metric allows for the determination of the actual volume of capital available to shareholders after the complete cessation of the company's operating activities.

Analisis pesaing TRACON Pharmaceuticals

TEM: Ekuitas Perusahaan|Nilai Buku Perusahaan Qiagen N.V.|ionispharma.com (IONS) - Kapitalisasi Akuntansi|Kapitalisasi Buku Repligen (RGEN)|Kapitalisasi Akuntansi RNA|Nilai Buku Perusahaan CRISPR Therapeutics Corp CRSP|Kapitalisasi Akuntansi GeneDx Corp (WGS)|Kapitalisasi Buku RARE (Ultragenyx Pharmaceutical)|BEAM - Kapitalisasi Buku|Aset Bersih Perusahaan Sarepta SRPT|TWST: Total Aset Bersih|Nilai Buku Perusahaan 10x Genomics Corp TXG|Intellia Corp (NTLA) - Nilai Akuntansi Perusahaan|STOK (Stoke Therapeutics) - Kapitalisasi Buku|Kapitalisasi Buku biolifesolutions.com|Kapitalisasi Buku WVE (Wave Life Sciences Ltd.)|Aset Bersih Perusahaan MAZE (Maze Therapeutics, Inc.)|SION: Nilai Buku Perusahaan|Prime Medicine Bio - Ekuitas Perusahaan|Taysha Gene Therapies (TSHA) - Nilai Buku Perusahaan|uniqure.com (QURE) - Kapitalisasi Akuntansi|Aset Bersih Perusahaan MeiraGTx MGTX|RGNX (REGENXBIO Inc) - Nilai Akuntansi Perusahaan|Nilai Buku Perusahaan Solid Bio SLDB|Nilai Aset Bersih Ocugen Pharma|Pacific Biosciences (PACB) - Kapitalisasi Buku|Nilai Akuntansi Perusahaan benitec.com (BNTC)|Kapitalisasi Buku DSGN (Design Therapeutics, Inc.)|Rocket Pharma - Kapitalisasi Buku|Nilai Buku Perusahaan 4D Molecular Therapeutics Inc (FDMT)|LXEO: Nilai Akuntansi Perusahaan|KRRO (korrobio.com) - Nilai Buku Perusahaan|editasmedicine.com (EDIT) - Aset Bersih Perusahaan|SLN (Silence Therapeutics plc) - Kapitalisasi Buku|Kapitalisasi Buku ProQR Therapeutics NV|Kapitalisasi Buku CDXS (Codexis, Inc.)|Aset Bersih Perusahaan Sangamo BioSciences (SGMO)|NAUT: Kapitalisasi Buku|MGX - Ekuitas Perusahaan|Precision BioSciences - Aset Bersih Perusahaan|Generation Bio Co. (GBIO) - Kapitalisasi Buku|BOLD - Aset Bersih Perusahaan|Exicure (XCUR) - Total Aset Bersih|IMNN: Kapitalisasi Buku|Pambiji Buku Bisnis RXi Pharmaceuticals|Kapitalisasi Buku MBIO (Mustang Bio, Inc.)|Aset Bersih Perusahaan transcodetherapeutics.com (RNAZ)|Kapitalisasi Buku BNGO (Bionano Genomics)|Applied DNA Corp - Kapitalisasi Buku|BLUE - Nilai Buku Perusahaan|IPA: Nilai Buku Perusahaan|Omega Therapeutics, Inc. - Nilai Buku Perusahaan|Pambiji Buku Bisnis Singular Genomics Systems, Inc.|Regulus Therapeutics Inc (RGLS) - Aset Bersih Perusahaan|Total Aset Bersih Syros Pharmaceuticals, Inc|Kapitalisasi Buku TBIO (Telesis Bio, Inc.)|Aset Bersih Perusahaan UBX (unitybiotechnology.com)